Back to medications
Medication monograph
levomilnacipran
Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)AntidepressantsAntidepressive Agents Indicated for DepressionSerotonin and Noradrenaline Reuptake InhibitorsSelective Serotonin- and Norepinephrinereuptake Inhibitors
Clinical reference
Product monograph
LEVOMILNACIPRAN capsule, extended release
Brands & formulations
Family members
FETZIMA
Marketed20 MGORALCAPSULE (EXTENDED RELEASE)[
"levomilnacipran (levomilnacipran hydrochloride)"
]
Product monograph FETZIMA
Marketed40 MGORALCAPSULE (EXTENDED RELEASE)[
"levomilnacipran (levomilnacipran hydrochloride)"
]
Product monograph FETZIMA
Marketed80 MGORALCAPSULE (EXTENDED RELEASE)[
"levomilnacipran (levomilnacipran hydrochloride)"
]
Product monograph FETZIMA
Marketed120 MGORALCAPSULE (EXTENDED RELEASE)[
"levomilnacipran (levomilnacipran hydrochloride)"
]
Product monograph Pricing
Price information
Fetzima Capsule
Abbott · 20 mg
30: $217.1390: $631.41
Fetzima Capsule
Abbvie · 20 mg
30: $217.1390: $631.41
Fetzima Capsule
Abbott · 40 mg
30: $231.4190: $674.27
Fetzima Capsule
Abbott · 80 mg
30: $245.790: $717.13
Fetzima Capsule
Abbvie · 120 mg
30: $271.4190: $757.13
Classification
- Chemical class
- Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
- Clinical class
- Antidepressants
- Banks class
- Antidepressive Agents Indicated for Depression, Serotonin and Noradrenaline Reuptake Inhibitors
- AHFS family
- Selective Serotonin- and Norepinephrinereuptake Inhibitors